Project Grant R01HL171401
Award Date
7/16/24
Completion Date
5/31/28
Dollars Obligated
$769K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Toledo, OH 43614, USA
Similar Awards
This $639,151 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support research to investigate sex differences in the role of gut microbiota and the immune system in salt-sensitive hypertension and associated kidney damage. The primary objectives are to: 1) Determine how the gut microbiota drives sex differences in salt-sensitive hypertension in a rat model, 2) Assess how male versus female gut...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Program (CFDA 93.837), will provide $616,521 to Baylor College of Medicine to investigate the role of bacterial extracellular vesicles (EVs) in the gut-brain axis and their contribution to the development of hypertension. The research aims to: 1) identify the specific bacterial origin of EVs involved in hypertension and examine the role of EV components like...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $651,840 to the University of Toledo Health Science Campus Division to develop a urine-based Kidney Tubule Health Panel (KTHP) biomarker system. The goal is to improve monitoring of kidney function during treatment for resistant hypertension, which often leads to changes in creatinine levels that are mistaken for acute...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), provides $604,818 to the University of Mississippi Medical Center to investigate the role of non-alcoholic fatty liver disease (NAFLD) in the development of cardiovascular disease. The key objectives are to determine whether increasing plasma levels of the ketone body β-hydroxybutyrate (BHB) or the hepatokines nerve growth factor...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to investigate the role of the acid ceramidase-sphingosine-1-phosphate (AC-S1P) pathway in the regulation of sodium excretion and the pathogenesis of salt-sensitive hypertension. The $467,473 award to Virginia Commonwealth University (VCU) will support a 5-year research...
This federal Project Grant award, valued at $1,092,000.00, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports research to elucidate the molecular and physiological mechanisms controlling vasomotor function, arterial stiffness, and blood pressure at the intersection of the renin-angiotensin system and the PPARG-RHOBTB1-CULLIN-3 pathways. Key research questions include identifying the substrates...
The University of Iowa has been awarded a $717,236 Project Grant (R01HL172944) from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). This 4-year grant, with an award date of December 15, 2024 and an ultimate completion date of November 30, 2028, will support research to study the role of neuronal primary cilia in hypertension, autonomic dysfunction, and body fluid imbalance. The research aims to evaluate how conditional...
The federal Project Grant award R01HL179780, totaling $743,302.00, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports research to investigate how gut microbe-derived lipids, specifically n-acyl amides, can signal through the host G protein-coupled receptor GPR119 to regulate inflammatory and metabolic pathways related to cardiometabolic diseases such as obesity, diabetes, and...
This $461,556 Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to explore the role of proteinase Factor XIIa (FXIIa) in the progression of dilated cardiomyopathy (DCM) and heart failure with reduced ejection fraction (HFrEF). The award will fund research to understand whether FXIIa contributes to the development of HFrEF by enhancing activation of the renin-angiotensin-aldosterone...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,568,003 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to the University of South Alabama to investigate the molecular mechanisms by which the protein progranulin regulates endothelial cell function and blood pressure control. The research aims to determine if reduced endothelial progranulin levels contribute to the development and progression of hypertension through oxidative stress and endothelial dysfunction....